Medical Condition News

RSS

Healthy neurons form surprising connections with aggressive brain cancer cells

In a collaborative study by the University of Bergen, Universität Heidelberg and Das Deutsche Krebsforschungszentrum in Germany, researchers discovered that cancer cells in the brain communicate with healthy brain cells in a different way than previously assumed.

27 Sep 2019

Researchers identify genetic variants related to starting point of Parkinson's disease

Researchers from the Institute of Neurosciences of the University of Barcelona, Hospital Clínic and the August Pi i Sunyer Biomedical Research Institute have identified a group of genetic variants related to the starting point of Parkinson's disease.

27 Sep 2019

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.

27 Sep 2019

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.

27 Sep 2019

Large-scale Autism study reveals inaccuracies in screening tests

A study has revealed that the most common screening tool used to detect autism among toddlers could be less than accurate.

27 Sep 2019

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

New data from the randomized, placebo-controlled TWILIGHT trial found that compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial infarction, or stroke in high-risk patients who have undergone successful percutaneous coronary intervention and completed three months of dual antiplatelet therapy.

27 Sep 2019

WHO begins emergency vaccination campaign to slow measles outbreak in DR Congo

The WHO and government of the DR Congo have begun an emergency vaccination program to stop the spread of measles in the country.

27 Sep 2019

Pioneering melanoma test to be made available within two years

Scientists have developed a pioneering new test that can more accurately predict whether melanoma, a type of skin cancer, is likely to return.

27 Sep 2019

How tau protein causes brain damage in Alzheimer’s disease

Researches have described a new technique to find out how Alzheimer's disease (AD) affects nerve cells.

27 Sep 2019

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.

27 Sep 2019

PWSA (USA) announces support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019

Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.

27 Sep 2019

Biological clock responds positively to stress

In a recent study, researchers found that the integrated stress response (ISR) is essential to stimulate the circadian clock.

27 Sep 2019

DataArt launches 'SkinCareAI' prototype app to detect early signs of melanoma

Global technology consultancy DataArt announced today the launch of “SkinCareAI” - a prototype app that analyses skin images to detect early signs of melanoma.

27 Sep 2019

Better methods needed to identify people at risk for liver disease

While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

27 Sep 2019

Study may help scientists to learn more about the causes of chronic pain

Researchers from North Carolina State University have found that inflammation increases neuronal activity, gene expression and sensory nerve (neurite) outgrowth in neurons involved in thermal - but not physical- sensations in mice.

27 Sep 2019

New study on gene modulation may help prevent blindness

Genes borrowed from a spider turned Peter Parker into Spiderman. If scientists can use archaea--tiny organisms similar to bacteria--as a source of useful genes for humans, might it help prevent blindness one day?

27 Sep 2019

DNA sequencing helps confirm breast cancer link between Leicester sisters

Two Leicester sisters who had their entire genomes sequenced in the hope of finding answers to their family history of breast cancer have learnt they both carry a genetic variant that significantly increases their risk of developing the disease.

27 Sep 2019

Study: Universal screening tool for autism is less accurate than shown in previous studies

In the first large, real-world study of universal screening for autism spectrum disorder (ASD) in toddlers, researchers at Children's Hospital of Philadelphia (CHOP) have found that the most widely used and researched screening tool is less accurate than shown in previous studies conducted in research laboratory settings.

27 Sep 2019

New analysis shows disparities persist in preemptive kidney transplantation

A recent analysis reveals persistent disparities in preemptive transplantation, when a patient receives a kidney transplant before ever starting dialysis, despite efforts to correct inequalities in transplantation. The findings appear in an upcoming issue of CJASN.

27 Sep 2019

CDC to fund sickle cell disease surveillance

The Centers for Disease Control and Prevention (CDC) has announced a funding of $1.2 million to different states in order to collect data and information from people suffering from sickle cell disease. The program called the Sickle Cell Data Collection program or SCDC is at present functional in two states - California and Georgia. With the new funds coming in, nine states would be able to collect and send population based information on the health of persons living with sickle cell disease.

27 Sep 2019